Over 140 New Jersey Auctions End Tomorrow 08/02 - Bid Now
Over 1700 Total Lots Up For Auction at Three Locations - OK 08/04, CA 08/06, NJ Cleansweep 08/17

Dr. Amy Abernethy

Verily appoints health data expert and former FDA principal deputy commissioner as president of Verily's clinical research platforms
June 15, 2021
Amy Abernethy
South San Francisco, CA – June 3, 2021 – Verily, an Alphabet company, today announced the appointment of Amy Abernethy, M.D., Ph.D. as President of Verily's clinical research business. Verily’s clinical research started with the Baseline program, a suite of studies using patient-centric tools for research data collection. Today's announcement foreshadows Verily’s planned expansion into a full-scale clinical evidence generation platform supporting a broad range of clinical trials and real-world evidence (RWE) studies. As President of this business unit, Dr. Abernethy will oversee this overall product vision and Verily’s related clinical research portfolio.

Dr. Abernethy was most recently Principal Deputy Commissioner of Food and Drugs of the US Food and Drug Administration (FDA) and the agency's acting Chief Information Officer. In just over two years with FDA, Dr. Abernethy is credited with having catalyzed enduring changes in the way the FDA uses data as well as advancing FDA's work in RWE and personalized medicine. She also spearheaded FDA's shift toward cloud-based data interoperability, thereby streamlining the agency's interaction with the health data ecosystem as outlined in the agency's technology and data modernization action plans.

"There is no one better positioned to catapult Verily's clinical research business into its next important phase than Amy, with her understanding of clinical practice, research, data science and the evolving regulatory environment," said Andy Conrad, Chief Executive Officer and founder of Verily. "Amy has been at the forefront of the use of clinical data to accelerate clinical trials and enable the uptake of real-world evidence. Her focus on improving the efficiency of the development and availability of new medicines aligns with our goals to transform clinical research by making it easier and faster to run clinical studies."

Servicing GE, Philips and Siemens CT equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

"The COVID-19 pandemic has underscored the importance of improving the clinical trials process, breaking down barriers to participation and speeding access to medicines," said Dr. Abernethy. "Verily is committed to accelerating and improving clinical research through the smart use of data, creative collaboration and unrivaled technical capabilities. Combined with their healthcare and device initiatives, Verily presents an unparalleled opportunity to improve patient care, which has been my driving force in every role I have played in the healthcare ecosystem."

You Must Be Logged In To Post A Comment